GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Livzon Pharmaceutical Group 000513.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

31.32

-0.10%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Livzon Pharmaceutical Group

Its shares trade on Shenzhen under the ticker 000513.SZ. It has been listed since 28 October 1993. In the fiscal year to 31 December 2025, it reported revenue of CN¥11.91bn and net income of CN¥2.02bn. At that date it held total assets of CN¥23.99bn and shareholders' equity of CN¥13.89bn.

Livzon Pharmaceutical Group Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zhuhai, Guangdong. LIVZON PHARMACEUTICAL GROUP INC. is a China based company principally engaged in the research and development, production and sales of pharmaceutical products. The firm's main products include western medicine preparation such as gastrointestinal drugs, cardiovascular drugs and antimicrobial drugs and gonadotrophin drugs, Chinese medicine preparation, active pharmaceutical ingredient and intermediates, diagnostic reagents and equipments. The firm distributes its products in the domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
28 Oct 1993
Employees
9,019

Leadership

Pay as last reported

  • Mr. Baoguo ZhuChairman of the Board, Non-Executive Director, since 2002CN¥3.3m
  • Mr. Yanggang TangPresident, Executive Director, since 2018TWD 5.8m
  • Mr. Guoxiang XuVice Chairman of the Board, Vice President, Executive DirectorTWD 5.5m
  • Mr. Desheng TaoVice Chairman of the Board, Non-Executive Director, since 2005TWD 3.0m
  • Ms. Yanxia SiFinance Director, Vice President, since 2014CN¥3.5m
  • Mr. Jun DuVice PresidentTWD 5.2m
  • Ms. Yuxuan HuangVice PresidentTWD 2.4m
  • Mr. Daping LiuVice President
  • Mr. Daihong YangVice President, since 2006TWD 3.7m
  • Mr. Liang YangVice PresidentTWD 2.4m
  • Ms. Ning LiuSecretary of the Board, Company Secretary
  • Mr. Nanqi LinDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
92
Environment
99
Social
99
Governance
78
Direct emissions (scope 1)
194,440.58 t
Energy emissions (scope 2)
326,718.79 t
Women in the workforce
47.45781%
Carbon reduction policy
No
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Livzon Pharmaceutical Group Inc has several strengths that contribute to its competitive advantage:

Weaknesses

  • Despite its strengths, Livzon Pharmaceutical Group Inc also experiences certain weaknesses:

Opportunities

  • Livzon Pharmaceutical Group Inc can capitalize on the following opportunities:

Threats

  • Livzon Pharmaceutical Group Inc faces the following threats that may pose challenges:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.